COVID-19 - Funding Opportunities

COVID-19 - Funding Opportunities

In the following, we summarise funding opportunities concerning the COVID-19 pandemic.

BioM supports biopharmaceutical companies in implementing their ideas and projects. Therefore, we are happy to help you find the right funding programmes and contact persons. Please contact us at info@remove-this.bio-m.org.

Bavarian Funding Possibilities

Call for funding Bavarian Therapy Strategy to Combat the COVID-19 Pandemic (Call for funding "BayTherapie2020"), (Deadline: January 31, 2021).

National Funding Information

Bundesministerium für Bildung und Forschung (BMBF)
Coronavirus: Advice and administration

Guideline to support research and development of urgently needed therapeutics against SARS-CoV-2. (Deadline: February 17, 2021)

Special programme to accelerate research and development of urgently needed vaccines against SARS-CoV-2

4th Call Computational Life Sciences - AI Methods for Infection Research

Nationale Kontaktstelle Lebenswissenschaften
Overview of COVID-19 funding programs

EU-Funding Opportunities

EU Commission - Horizon 2020

COVID-X: Defeating COVID-19 with Data Solutions (Deadline: January 27, 2021)

European Research Area (ERA) corona platform

The Research Executive Agency (REA) provides information on the effects on application submission, review and project processing in Horizon 2020 . Information is available on MSC-measures.

HERA Incubator
European bio-defence preparedness plan against COVID-19 variants

Other Funding Opportunities

Novartis
Broad range of initiatives to respond to COVID-19 Pandemic

Blumorpho und EuroScan
Together against the Covid-19 pandemic

Science|Business
Science|Business Database: Coronavirus Funding Opportunities

JEDI (Joint European Disruptive Initiative)
Billion Molecules against COVID-19 Grand Challenge

Creative Destruction Lab
CDL Recovery

Dr. Petra Burgstaller
Dr. Petra Burgstaller

Head of inQlab


Christina Enke-Stolle
Christina Enke-Stolle

Head of inQlab